HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 80 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $422,000 | -26.6% | 47,600 | +4.6% | 0.00% | -33.3% |
Q2 2022 | $575,000 | -26.1% | 45,500 | +10.7% | 0.00% | -25.0% |
Q1 2022 | $778,000 | -45.4% | 41,100 | +1.2% | 0.00% | -33.3% |
Q4 2021 | $1,424,000 | +25.2% | 40,600 | +29.7% | 0.01% | +20.0% |
Q3 2021 | $1,137,000 | +26.5% | 31,300 | +36.7% | 0.01% | +25.0% |
Q2 2021 | $899,000 | +38.9% | 22,900 | 0.0% | 0.00% | +33.3% |
Q1 2021 | $647,000 | -15.1% | 22,900 | -3.8% | 0.00% | -25.0% |
Q4 2020 | $762,000 | +2.1% | 23,800 | +3.0% | 0.00% | 0.0% |
Q3 2020 | $746,000 | +12.2% | 23,100 | -4.1% | 0.00% | 0.0% |
Q2 2020 | $665,000 | +79.2% | 24,100 | +15.9% | 0.00% | +33.3% |
Q1 2020 | $371,000 | -31.5% | 20,800 | -3.7% | 0.00% | 0.0% |
Q4 2019 | $542,000 | +71.5% | 21,600 | +22.0% | 0.00% | +50.0% |
Q3 2019 | $316,000 | -12.0% | 17,700 | +8.6% | 0.00% | 0.0% |
Q2 2019 | $359,000 | -24.7% | 16,300 | +4.5% | 0.00% | -33.3% |
Q1 2019 | $477,000 | +71.0% | 15,600 | +28.9% | 0.00% | +50.0% |
Q4 2018 | $279,000 | – | 12,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERAL ATLANTIC, L.P. | 4,000,000 | $67,760,000 | 1.05% |
M&G INVESTMENT MANAGEMENT LTD | 7,084,834 | $120,442,178 | 0.54% |
Bellevue Group AG | 1,802,963 | $30,584,761 | 0.49% |
AIA Group Ltd | 391,278 | $6,628,249 | 0.32% |
PLATINUM INVESTMENT MANAGEMENT LTD | 182,052 | $3,083,961 | 0.12% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 4,219,168 | $71,472,706 | 0.11% |
Hennion & Walsh Asset Management, Inc. | 51,735 | $876,391 | 0.06% |
Allianz Asset Management GmbH | 1,644,999 | $27,866,283 | 0.05% |
Janney Capital Management LLC | 17,203 | $291 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 193,811 | $3,268 | 0.01% |